Saturday, 24 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Sino Medical Sciences' HT Supreme Stent System Gains Vietnamese Marketing Approval
CompanyMedical Device

Sino Medical Sciences’ HT Supreme Stent System Gains Vietnamese Marketing Approval

March 6, 2025
Yifan Pharma Secures Rights to Bayer’s Stivarga and Nexavar in China
CompanyDeals

Yifan Pharma Secures Rights to Bayer’s Stivarga and Nexavar in China

March 6, 2025
Major Policy Directions in China's Healthcare Arena: A Comprehensive Breakdown
Policy / Regulatory

Major Policy Directions in China’s Healthcare Arena: A Comprehensive Breakdown

March 7, 2025
RongCan Biotech's mRNA HPV Vaccine Receives FDA Clinical Approval
CompanyDrug

RongCan Biotech’s mRNA HPV Vaccine Receives FDA Clinical Approval

March 6, 2025
Insilico Medicine and Tenacia Partner on AI-Driven CNS Therapies
CompanyDeals

Insilico Medicine and Tenacia Partner on AI-Driven CNS Therapies

March 6, 2025
Lexenpharm and Sun-Novo Partner on Long-Acting Asthma and COPD Drugs
CompanyDeals

Lexenpharm and Sun-Novo Partner on Long-Acting Asthma and COPD Drugs

March 6, 2025
Baheal Pharmaceutical Gains Exclusive Rights to Roche's MabThera in China
CompanyDeals

Baheal Pharmaceutical Gains Exclusive Rights to Roche’s MabThera in China

March 6, 2025
Zhejiang Huahai's HB0034 Meets Primary Endpoint in GPP Study
CompanyDrug

Zhejiang Huahai’s HB0034 Meets Primary Endpoint in GPP Study

March 6, 2025
CStone Pharmaceuticals and SteinCares Ink Licensing Deal for PD-L1 Inhibitor in Latin America
CompanyDeals

CStone Pharmaceuticals and SteinCares Ink Licensing Deal for PD-L1 Inhibitor in Latin America

March 6, 2025
Fosun Pharma's 24-Valent Pneumococcal Vaccine Receives NMPA Approval for Phase I Trial
CompanyDrug

Fosun Pharma’s 24-Valent Pneumococcal Vaccine Receives NMPA Approval for Phase I Trial

March 6, 2025
Bio-Thera Solutions Inks Licensing Deal with World Medicine for BAT2206
CompanyDeals

Bio-Thera Solutions Inks Licensing Deal with World Medicine for BAT2206

March 5, 2025
Hainan Poly Pharm's US Partner Slate Run Pharmaceuticals Collaborates with Premier on Contrast Agents
CompanyDeals

Hainan Poly Pharm’s US Partner Slate Run Pharmaceuticals Collaborates with Premier on Contrast Agents

March 5, 2025
1 2 … 230 231 232 233 234 … 289 290
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up